AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

172.310

+0.7400.43%

Volume:1.50M

Turnover:259.17M

Market Cap:82.52B

PE:-23.01

High:175.365

Open:172.800

Low:171.000

Close:171.570

52wk High:219.589

52wk Low:90.000

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.27

T/O Rate:0.31%

Dividend:4.12

Dividend Rate:2.39%

EPS(TTM):-7.488

EPS(LYR):-7.488

ROE:-15.83%

ROA:7.26%

PB:3.98

PE(LYR):-23.01

Loading ...

Overview Company News Filings

Australian Dividend Stocks With Income Support Investors May Want To Check

Simply Wall St.

Australian Dividend Stocks With Strong Yields and Staying Power

Simply Wall St.

CSL Stock And 2 Australian Dividend Shares With Income That Looks More Reliable

Simply Wall St.

QBE Stock And 2 Australian Dividend Shares For Passive Income

Simply Wall St.

EU: Seeks Feedback on Commitments from Sanofi over Possible Anti-competitive Conduct Regarding Rival Flu Vaccine for Vulnerable Patients

THOMSON REUTERS

CSL Stock Leads 3 Australian Dividend Shares Worth A Closer Look

Simply Wall St.

Commonwealth Bank Stock And Other Dividend Compounders For Reliable Income

Simply Wall St.

Carlisle Companies (CSL) Is Down 5.6% After Exit From Key Russell Defensive Indices Is The Bull Case Changed?

Simply Wall St.

QBE Stock And 2 Australian Dividend Shares For Income Focused Portfolios

Simply Wall St.

Does CSL (ASX:CSL) Losing TAVNEOS Authorisation Undermine Its Diversification And Regulatory Resilience Story?

Simply Wall St.

Commonwealth Bank Stock And 2 Australian Dividend Shares For Reliable Income

Simply Wall St.

Australian Healthcare Stocks at Two-month High, CSL Rises over 3%

Is CSL (ASX:CSL) Cheap On Tavneos Revocation Risk?

Simply Wall St.

3 Dividend Growth Stocks Riding Grid And Industrial Spending Trends

Simply Wall St.

Commonwealth Bank Stock And 2 Australian Dividend Shares Worth A Closer Look

Simply Wall St.

Csl's Latest Blow Supports Continued Caution

Market Chatter: Carlisle Companies Made Unsolicited Offers for Owens Corning

MT Newswires Live

CSL to Cease New Patient Initiation for Tavneos in EU and Eea Markets

CSL Says CHMP Recommends Revocation of TAVNEOS Marketing Authorization in Europe

MT Newswires Live

To Provide Details on Tavneos Ip Impairment in 2026 Full Year Results

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/CSL.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":172.31,"timestamp":1788243120000,"preClose":171.57,"halted":0,"volume":1501636,"delay":0,"changeRate":0.004313108352276092,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.487984234644033,"marketStatus":"Closed","change":0.74,"latestTime":"09-01 16:12:00 AEST","open":172.8,"high":175.365,"low":171,"amount":259171238,"amplitude":0.025442,"askPrice":172.31,"askSize":5,"bidPrice":172.2,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-7.487984234644033,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":171.57,"dividendRate":0.023897,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":1.265648,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":171.57,"auctionPrice":172.33,"auctionVolume":317793,"auctionTime":1788243005735,"referencePrice":172.31,"referenceTime":1788258603092,"auction":3,"marketStatus":"盘后竞价","timestamp":1788243005735}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.487984,"volumeRatio":1.265648,"shares":478911979,"dividePrice":4.1177,"high":175.365,"amplitude":0.025442,"preClose":171.57,"low":171,"week52Low":90,"pbRate":"3.98","psRate":"3.73","week52High":219.589,"institutionHeld":0,"latestPrice":172.31,"committee":0.960784,"eps":-7.487984234644033,"divideRate":0.023897,"volume":1501636,"delay":0,"ttmEps":-7.487984234644033,"open":172.8,"prevYearClose":170.408,"prevWeekClose":172.32,"prevMonthClose":171.57,"prevQuarterClose":114.74,"fiveDayClose":173.64,"twentyDayClose":128.83,"sixtyDayClose":99.47,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.018567360626050477},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651121710","title":"Australian Dividend Stocks With Income Support Investors May Want To Check","url":"https://stock-news.laohu8.com/highlight/detail?id=2651121710","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651121710?lang=en_us&edition=fundamental","pubTime":"2026-07-14 09:31","pubTimestamp":1783992684,"startTime":"0","endTime":"0","summary":"With oil prices, bond yields and inflation worries back in focus, many investors are looking for income that feels steadier than the latest headline. That is where the Dividend Powerhouses screener comes in. It zeroes in on stocks with a 5%+ yield that is covered by earnings, growing and historically stable. Instead of chasing short-term market swings, you are focusing on companies that have made regular cash payouts a core part of their story. In this article, you will see three of the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-income-support-investors-may","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-income-support-investors-may","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GDX","XKO.AU","GOAU","XAO.AU","SGDM","GDXY","RING","GXDW","GOLY","PICK","PHYS","BAR","GLTR","JNUG","UGL","UYM","BTGD","DGP","CEF","EVN.AU","IAUI","DULL","DZZ","XJO.AU","AAAU","IAUM","XME","NST.AU","PPI","GBUG","DECU","ISBC","VOTE","DBC","CSL.AU","GLDM","GDXU","BEGS","OUNZ","DUST","GDXD","SGOL","JDST","SHNY","FEBU","FGDL","GDXJ","IAU","USG","GLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651169354","title":"Australian Dividend Stocks With Strong Yields and Staying Power","url":"https://stock-news.laohu8.com/highlight/detail?id=2651169354","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651169354?lang=en_us&edition=fundamental","pubTime":"2026-07-13 04:28","pubTimestamp":1783888093,"startTime":"0","endTime":"0","summary":"With inflation trends mixed across regions and central banks weighing their next moves, many investors are looking for income streams that feel steadier than headline news. The Dividend Powerhouses (3%+ Yield) screener focuses on companies offering dividend yields above 5% that are described as well covered, growing and stable. That combination can appeal if you want your portfolio to lean on cash returns while bond markets and policy expectations keep shifting. In this article, you will see...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-strong-yields-and-staying-po","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-strong-yields-and-staying-po","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SHNY","PW","QBE.AU","GLL","XJO.AU","CSL.AU","IAUM","GDXY","IAUI","OUNZ","BAR","IAU","OZR.AU","PPI","CEF","SGDM","GBUG","RING","XAO.AU","GLTR","DUST","GLDM","EVN.AU","GDXJ","DULL","VIG","UGL","FGDL","SGOL","JDST","PICK","XME","AAAU","BTGD","PHYS","USG","DBC","GDXD","GOLY","GDXU","BEGS","ZYAU.AU","UYM","XKO.AU","GOAU","GEAR.AU","DZZ","DGP","JNUG","GDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650815260","title":"CSL Stock And 2 Australian Dividend Shares With Income That Looks More Reliable","url":"https://stock-news.laohu8.com/highlight/detail?id=2650815260","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650815260?lang=en_us&edition=fundamental","pubTime":"2026-07-12 01:33","pubTimestamp":1783791231,"startTime":"0","endTime":"0","summary":"With inflation trends mixed across regions and bond yields easing in several major markets, many investors are looking for income that feels more reliable than short term sentiment swings. The Dividend Powerhouses (3%+ Yield) screener focuses on companies paying more than a 5% dividend yield that is described as well covered, growing and stable, which can appeal if you want cash returns while policy expectations and growth signals keep shifting. In this article, you will see three stocks from...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-with-income-that","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-with-income-that","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","SGXZ23171101.USD","IMLC.AU","DECU","VOTE","E200.AU","VGFPF","XAO.AU","QFN.AU","CSL.AU","IOZ.AU","CSL","LU0728928796.USD","BK7067","IIGF.AU","SG9999004303.SGD","BEAR.AU","BK7511","QBE.AU","FEBU","BBOZ.AU","BK7506","GEAR.AU","XKO.AU","BK7508","STW.AU","SLF.AU","OZR.AU","VAS.AU","LU1169589451.USD","VAP.AU","ZYAU.AU","GIVE.AU","EVN.AU","EIGA.AU","BK4535","BK7104","XJO.AU","SPHQ","OZF.AU","QRE.AU","UYM","VIG","DACE.AU","GXDW","BK4086","BK7034","PICK","IISV.AU","XME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185389","title":"QBE Stock And 2 Australian Dividend Shares For Passive Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185389","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185389?lang=en_us&edition=fundamental","pubTime":"2026-07-10 13:27","pubTimestamp":1783661267,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses, often grouped with Dividend Aristocrats, can be especially appealing when inflation trends, bond yields and growth expectations are all pulling investors in different directions. With central banks weighing their next moves and energy prices influencing both inflation and income assets, a screen that focuses on dividend yields above 5% that are well covered, growing and stable offers a clear, rules based way to seek income from equities. This article highlights three...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-passive-incom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-passive-incom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLF.AU","GDXJ","AAAU","PHYS","GBUG","XKO.AU","GLTR","SHNY","GDXY","XME","GDXU","SGOL","BEGS","QBE.AU","GOAU","PICK","VIG","USG","XJO.AU","IAU","JDST","GLDM","VAS.AU","BTGD","EVN.AU","UGL","DGZ","RING","XAO.AU","UYM","BBOZ.AU","IAUI","GDX","JNUG","GLL","GOLY","DULL","BAR","DUST","OUNZ","CSL.AU","IAUM","SGDM","DBC","DZZ","PPI","CEF","GDXD","DGP","FGDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649696268","title":"EU: Seeks Feedback on Commitments from Sanofi over Possible Anti-competitive Conduct Regarding Rival Flu Vaccine for Vulnerable Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2649696268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649696268?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:45","pubTimestamp":1783503900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nS8N41H0FB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7067","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649579709","title":"CSL Stock Leads 3 Australian Dividend Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2649579709","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649579709?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:24","pubTimestamp":1783481061,"startTime":"0","endTime":"0","summary":"With inflation signals mixed across regions and interest rate expectations constantly reassessed, many investors are turning to dividend powerhouses for more predictable income. The Dividend Powerhouses (3%+ Yield) screener focuses on companies paying more than a 5% yield that appears well covered, growing and stable, which can be especially appealing when bond markets and central bank policy paths feel hard to read. Instead of trying to time every macro twist, you can focus on cash flows...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-leads-3-australian-dividend-shares-worth-a-closer","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-leads-3-australian-dividend-shares-worth-a-closer","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL.AU","QRE.AU","BK4588","QFN.AU","IISV.AU","XKO.AU","BBOZ.AU","SPHQ","IMLC.AU","VAP.AU","GBUG","VAS.AU","CSL","BK7034","XJO.AU","GEAR.AU","BK4086","QBE.AU","IIGF.AU","OZR.AU","BK7501","VIG","ZYAU.AU","DACE.AU","GIVE.AU","LU0728928796.USD","UYM","XAO.AU","BK4535","IOZ.AU","GOAU","BK7506","BK7067","EVN.AU","SLF.AU","BEGS","BK4585","BK7508","BK7511","GLTR","BEAR.AU","CEF","STW.AU","EIGA.AU","PICK","VOTE","E200.AU","XME","OZF.AU","DECU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679412","title":"Commonwealth Bank Stock And Other Dividend Compounders For Reliable Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679412","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679412?lang=en_us&edition=fundamental","pubTime":"2026-07-07 03:37","pubTimestamp":1783366654,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses with yields above 5% can be especially appealing when inflation signals are mixed, growth is cooling in places, and central banks are rethinking rate paths. While bond yields and policy guidance move around, a well covered, growing and stable dividend stream offers a clearer source of potential cash flow. This Dividend Powerhouses screener focuses on exactly that: companies that combine higher income with balance sheet discipline. In this article, you will see 3 of the...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-other-dividend-compounders-for-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-other-dividend-compounders-for-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SPHQ","UYM","BK7508","CBA.AU","GOAU","BK4585","VAP.AU","SLF.AU","IIGF.AU","GLTR","E200.AU","BBOZ.AU","QFN.AU","BK4588","BK7104","XAO.AU","XKO.AU","IOZ.AU","PICK","VAS.AU","ZYAU.AU","BK7501","IISV.AU","GEAR.AU","BK7067","QRE.AU","BK7506","CEF","BK4535","VIG","EVN.AU","GIVE.AU","BK7511","BEAR.AU","EIGA.AU","GBUG","CSL.AU","BEGS","BK7135","IMLC.AU","OZF.AU","XME","OZR.AU","DACE.AU","XJO.AU","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649136643","title":"Carlisle Companies (CSL) Is Down 5.6% After Exit From Key Russell Defensive Indices Is The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649136643","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649136643?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:18","pubTimestamp":1783304334,"startTime":"0","endTime":"0","summary":"On 27 June 2026, Carlisle Companies Incorporated (NYSE: CSL) was removed from the Russell 1000 Defensive, Russell 1000 Value-Defensive, and Russell 1000 Growth-Defensive indices, prompting rebalancing by index-tracking funds.\nThis simultaneous exit from multiple Russell 1000 defensive-style indices matters because it can alter Carlisle’s investor base and share-trading patterns, with implications for liquidity and ownership mix.\nWe’ll now examine how Carlisle’s removal from several Russell...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-is-down-56-after-exit-from-key-russel","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-is-down-56-after-exit-from-key-russel","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0728928796.USD","BK4585","LU1169589451.USD","CSL.AU","CSL","SG9999004303.SGD","SGLC","OMFL","SGXZ23171101.USD","DEUS","BK7508","BK4581","BK4086","BK7501","IWF","FLQL","BK4588","BK7511","BK7067","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649915618","title":"QBE Stock And 2 Australian Dividend Shares For Income Focused Portfolios","url":"https://stock-news.laohu8.com/highlight/detail?id=2649915618","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649915618?lang=en_us&edition=fundamental","pubTime":"2026-07-05 14:28","pubTimestamp":1783232896,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and growth signals pulling in different directions across regions, many investors are looking for income streams that feel more resilient than short term market moves. That is where Dividend Powerhouses, companies with yields above 5% that the screener flags as covered, growing and relatively stable, come in. These stocks can help turn market noise into a more predictable cash flow focus. In this article, you will see three stocks from the Dividend Powerhouses...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-income-focuse","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-income-focuse","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","GDXY","SGDM","USG","SHNY","UYM","EVN.AU","XME","GLTR","FGDL","CEF","GBUG","GDXU","IAUM","OUNZ","PPI","DUST","BEGS","IAUI","DECU","VOTE","DZZ","PHYS","GDX","AAAU","JDST","EIGA.AU","QBE.AU","CSL.AU","XJO.AU","UGL","DULL","GOLY","RING","PICK","XAO.AU","IAU","SGOL","GLL","DBC","JNUG","VIG","BTGD","OZR.AU","GDXD","GLDM","BAR","GDXJ","GOAU","DGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649691995","title":"Does CSL (ASX:CSL) Losing TAVNEOS Authorisation Undermine Its Diversification And Regulatory Resilience Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649691995","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649691995?lang=en_us&edition=fundamental","pubTime":"2026-07-04 22:25","pubTimestamp":1783175140,"startTime":"0","endTime":"0","summary":"The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended revoking CSL Vifor’s TAVNEOS marketing authorisation in the EU, after finding manipulated and unreliable pivotal trial data and prompting CSL to halt new patient starts across EMA jurisdictions.\nThis setback not only raises the prospect of an impairment charge for TAVNEOS intellectual property, but also highlights how regulatory scrutiny can directly test CSL’s diversification benefits and risk...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-losing-tavneos-authorisation-undermine-its-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-losing-tavneos-authorisation-undermine-its-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","SG9999004303.SGD","LU1169589451.USD","BK7501","BK7067","BK7508","CSL","LU0728928796.USD","LU1169590202.USD","BK4086","AIPO","SGXZ23171101.USD","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648165489","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares For Reliable Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2648165489","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648165489?lang=en_us&edition=fundamental","pubTime":"2026-07-03 14:36","pubTimestamp":1783060582,"startTime":"0","endTime":"0","summary":"In a world where inflation signals, interest rate expectations and growth data keep shifting, many investors are looking for income that feels more reliable than the latest macro headline. That is where Dividend Powerhouses with yields above 5% and well covered, growing payouts can help. This screener focuses on companies that have kept dividends both stable and on an upward path, which can be appealing when bond yields, labor data and central bank messages keep moving around. In this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLT","VAP.AU","IIGF.AU","BK7104","TMF","US3Y.BOND","IOZ.AU","EIGA.AU","BK7506","US12M.BOND","VAS.AU","STW.AU","US6M.BOND","SLF.AU","XAO.AU","E200.AU","BK7508","OZR.AU","IISV.AU","XJO.AU","XKO.AU","US10Y.BOND","BEAR.AU","CSL.AU","GIVE.AU","AIPO","BK7501","CHAT","ARTY","BK7067","BK7135","IMLC.AU","US5Y.BOND","US2Y.BOND","QRE.AU","US30Y.BOND","GEAR.AU","ZYAU.AU","BBOZ.AU","BK7511","NST.AU","CBA.AU","TLTW","AGIX","DACE.AU","QFN.AU","OZF.AU","US7Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648665536","title":"Australian Healthcare Stocks at Two-month High, CSL Rises over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648665536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648665536?lang=en_us&edition=fundamental","pubTime":"2026-07-03 13:48","pubTimestamp":1783057739,"startTime":"0","endTime":"0","summary":"BUZZ-Australian healthcare stocks at two-month high, CSL rises over 3%** Australian health stocks.AXHJrise as much as 2.7%, their highest level since April 22** Stocks gain more than 5% so far this week, their best level since early-November, 2022** Extends gains for a seventh consecutive week** \"Healthcare was battered in the last FY, and has been stabilising in the last couple of months, and investors are finally waking up to how cheap they are in a historical context,\" says Mark Gardner, founder and chief executive officer at MPC Markets** Shares of CSLCSL.AXand CochlearCOH.AXgain over 3% each** Sub-index down ~20% YTD, including the session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nL6N4350AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","COH.AU","BK7511","BK7007","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648021795","title":"Is CSL (ASX:CSL) Cheap On Tavneos Revocation Risk?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648021795","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648021795?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:46","pubTimestamp":1782981994,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is back in focus after the European Medicines Agency’s committee recommended revoking the EU marketing authorisation for Tavneos. This has raised fresh questions about the CSL Vifor unit and the stock’s recent recovery.\nSee our latest analysis for CSL.\nThe Tavneos setback arrives after a sharp 27.21% 1 month share price return for CSL. However, this sits against a weaker backdrop, with the stock down 31.52% year to date and the 1 year total shareholder return declining 49.94%,...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-tavneos-revocation-risk","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-tavneos-revocation-risk","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","BK4086","BK7508","BK7067","CSL.AU","LU1169589451.USD","SGXZ23171101.USD","BK7511","BK7501","CSL","LU0728928796.USD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593119","title":"3 Dividend Growth Stocks Riding Grid And Industrial Spending Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593119","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593119?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:20","pubTimestamp":1782861615,"startTime":"0","endTime":"0","summary":"Dividend growth stocks sit at an interesting crossroads for income investors who want more than just a static payout. When a company steadily lifts its dividend, it can signal confidence in its cash generation and a willingness to share that cash with shareholders. This article looks at how one recent news event may affect a select group of dividend growers, and what that could mean for your watchlist. Ahead, you will find three stocks from our Dividend Growth Stocks screener that appear...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-fast/fastenal/news/3-dividend-growth-stocks-riding-grid-and-industrial-spending","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-fast/fastenal/news/3-dividend-growth-stocks-riding-grid-and-industrial-spending","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","IE00B2PGVK34.USD","LU2264538146.SGD","IE00B19Z9505.USD","LU0957791311.USD","LU1861219969.SGD","BK4567","BK4086","LU1988902786.USD","LU2360107325.USD","LU0096362180.USD","CSL.AU","LU1815333072.USD","ETN","IE0004445239.USD","LU1169590202.USD","LU1074936037.SGD","IE00BFXG0V08.USD","BK4588","IE00BYQQ9H92.USD","FAST","IE0034235188.USD","VIG","LU1861214812.USD","BK4533","IE00B5TLWC47.USD","SGXZ23171101.USD","IE00B3CCJ633.GBP","LU2506951792.HKD","BK4585","LU1989764664.SGD","BK7508","BK7067","LU1064131342.USD","LU2357125470.USD","IE00B19Z8W00.USD","BK4543","LU0061474960.USD","IE00BZ199S13.USD","BK4096","IE00BZ1G4Q59.USD","LU2249611893.SGD","LU0823414551.USD","LU2294711713.HKD","CSL","LU1169589451.USD","IE00BGHQF417.EUR","BK7511","IE00BD6J9T35.USD","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647814495","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2647814495","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647814495?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:13","pubTimestamp":1782785612,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses can appeal when inflation, interest rates and consumer confidence are all in flux, as they are today. With policy paths diverging across the US, Europe and Asia, many investors are looking for income streams that are both sizeable and supported by stable cash flows. The Dividend Powerhouses (3%+ Yield) screener focuses on companies that pay a higher yield, with dividends that are covered and have a record of stability. This article highlights 3 stocks from that screener,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-wor","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-wor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK7135","IMLC.AU","E200.AU","XAO.AU","QFN.AU","CEF","CSL.AU","IOZ.AU","BK7067","IIGF.AU","BEAR.AU","BK7511","GLTR","BBOZ.AU","BEGS","BK7506","GEAR.AU","XKO.AU","BK7508","STW.AU","BK7501","SLF.AU","OZR.AU","VAS.AU","GBUG","VAP.AU","ZYAU.AU","GIVE.AU","EVN.AU","EIGA.AU","BK4535","BK7104","XJO.AU","BK4585","OZF.AU","QRE.AU","UYM","VIG","DACE.AU","GOAU","CBA.AU","PICK","IISV.AU","XME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588908","title":"Csl's Latest Blow Supports Continued Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588908","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647588908?lang=en_us&edition=fundamental","pubTime":"2026-06-30 07:56","pubTimestamp":1782777360,"startTime":"0","endTime":"0","summary":"2356 GMT - The almost certain withdrawal of the CSL-marketed Tavneos therapy in Europe only adds to Macquarie's caution toward the Australian biotechnology company. An analyst at the investment bank tells clients in a note that a European Commission ruling on the treatment appears to be a formality, and trims EPS forecasts by 3% for fiscal 2027 and by 4% for fiscal 2028. The analyst reiterates a neutral rating on the stock and reminds readers of the significant near-term earnings uncertainty across CSL's core business segments, plus ongoing medium-term competitive risks. Target price rises 2.7% to 114.00 Australian dollars, reflecting currency moves. Shares are at A$115.39 ahead of the open.  Dow Jones NewswiresJune 29, 2026 19:56 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7508","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647459306","title":"Market Chatter: Carlisle Companies Made Unsolicited Offers for Owens Corning","url":"https://stock-news.laohu8.com/highlight/detail?id=2647459306","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647459306?lang=en_us&edition=fundamental","pubTime":"2026-06-30 01:24","pubTimestamp":1782753884,"startTime":"0","endTime":"0","summary":"Carlisle Companies  has made multiple unsolicited offers to acquire Owens Corning , with a potential deal valued at over $10 billion, The Wall Street Journal reported Monday, citing people familiar with the matter.Owens Corning has not yet engaged substantially with Carlisle, the report said, adding that Carlisle is now evaluating its next move.Carlisle Companies, Owens Corning did not immediately respond to MT Newswires' request for comment.Price: 369.68, Change: -18.70, Percent Change: -4.81","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169589451.USD","LU0348723411.USD","LU2023250843.SGD","LU1974910355.USD","IE00BFMHRM44.USD","LU2543165471.USD","LU2357305700.SGD","SG9999004303.SGD","LU2041044095.USD","GLW","SGXZ23171101.USD","LU1720051017.SGD","LU2272731865.HKD","CSL.AU","BK4148","LU2272731782.SGD","BK4585","BK4086","LU2322448791.USD","LU2322448957.HKD","BK4588","LU2092937221.SGD","LU2106854487.HKD","LU2360108059.USD","LU1548497426.USD","BK7501","BK7067","BK7511","CNAV","BK7508","LU1992135399.USD","LU1992135472.HKD","LU0728928796.USD","LU1720051108.HKD","BK4512","IE00BGHQF417.EUR","OC","LU0868494617.USD","LU2272731600.USD","LU2473716301.USD","GLWG","CSL","LU1169590202.USD","LU2023250504.SGD","LU2048586759.USD","LU1917777945.USD","IE00B3CCJ633.GBP","LU2298321311.HKD","IE00B2PGVK34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647344990","title":"CSL to Cease New Patient Initiation for Tavneos in EU and Eea Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2647344990","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647344990?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:27","pubTimestamp":1782696438,"startTime":"0","endTime":"0","summary":"BRIEF-CSL To Cease New Patient Initiation For Tavneos In EU And Eea MarketsJune 29 -CSL LtdCSL.AX:TO CEASE NEW PATIENT INITIATION FOR TAVNEOS IN EU AND EEA MARKETSEMA CHMP RECOMMENDS REVOCATION OF EU MARKETING AUTHORISATION FOR TAVNEOS ON JUN 26TO PROVIDE DETAILS ON TAVNEOS IP IMPAIRMENT IN 2026 FULL YEAR RESULTSEXPECTS FY26 TAVNEOS SALES REVENUE OF ABOUT $145 MILLIONFurther company coverage:CSL.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN42Y121:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","CSL.AU","BK7067","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647334151","title":"CSL Says CHMP Recommends Revocation of TAVNEOS Marketing Authorization in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2647334151","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647334151?lang=en_us&edition=fundamental","pubTime":"2026-06-29 08:22","pubTimestamp":1782692567,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued an opinion recommending the revocation of the European Union marketing authorization","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7511","BK7508","BK7067","BK4087","EPV","LU1169589451.USD","SG9999004303.SGD","CSL","LU1169590202.USD","EEA","CHMP","SGXZ23171101.USD","BK4086","CSL.AU","LU0728928796.USD","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647534917","title":"To Provide Details on Tavneos Ip Impairment in 2026 Full Year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647534917?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7067","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}